Medical and minimally invasive therapies for the treatment of benign prostatic hyperplasia

  title={Medical and minimally invasive therapies for the treatment of benign prostatic hyperplasia},
  author={Richard C Harkaway and Muta M. Issa},
  journal={Prostate Cancer and Prostatic Diseases},
Over the last decade, management of benign prostatic hyperplasia (BPH) has changed with a substantial decrease in the use of transurethral prostatectomy (TURP) and a simultaneous increase in the use of medical therapy and minimally invasive surgical therapy (MIST). The goal of management of this chronic progressive condition is not only to provide relief of lower urinary tract symptoms (LUTS) but also to reduce the lifetime risk of adverse outcomes. Recent clinical evidence has demonstrated a… CONTINUE READING
17 Citations
75 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 17 extracted citations


Publications referenced by this paper.
Showing 1-10 of 75 references

Contemporary Diagnosis and Management of Diseases of the Prostate

  • MM Issa, FF Marshall
  • 3rd edn. Handbooks in Health Care Co.: Newtown,
  • 2005

Effects of alpha-blockers on ejaculatory function in normal subjects

  • JG Hellstrom, W Smith, SC. Sikka
  • J Urol
  • 2005

Nordling J, for the European Association of Urology. Guidelines on benign prostatic hyperplasia

  • JJ de la Rosette, S Madersbacher, G Alivizatos, C Rioja Sanz, M Emberton
  • Available at…
  • 2005

Similar Papers

Loading similar papers…